GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dechra Pharmaceuticals PLC (LSE:DPH) » Definitions » Short Interest

Dechra Pharmaceuticals (LSE:DPH) Short Interest


View and export this data going back to 2000. Start your Free Trial

What is Dechra Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Dechra Pharmaceuticals's Short Interest

For the Drug Manufacturers - General subindustry, Dechra Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dechra Pharmaceuticals's Short Interest Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dechra Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where Dechra Pharmaceuticals's Short Interest falls into.


Dechra Pharmaceuticals (LSE:DPH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dechra Pharmaceuticals PLC (LSE:DPH) » Definitions » Short Interest
Comparable Companies
LSE:VOX LSE:CMB LSE:BLU LSE:SDVP LSE:ARGO LSE:INV LSE:WCW LSE:WINV LSE:SVM LSE:BRH LLY JNJ MRK ABBV XSWX:ROG XSWX:NOVN LSE:AZN AMGN PFE XPAR:SAN
Traded in Other Exchanges
DPHAY:USA DPHl:UK 1PK:Germany
Address
24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, GBR, CW9 7UA
Website
https://www.dechra.com
Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.

Dechra Pharmaceuticals (LSE:DPH) Headlines

No Headlines